➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Baxter
Mallinckrodt
Dow

Last Updated: July 16, 2020

DrugPatentWatch Database Preview

Quinidine sulfate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for quinidine sulfate and what is the scope of patent protection?

Quinidine sulfate is the generic ingredient in four branded drugs marketed by Solvay, Lilly, Wyeth Pharms Inc, Cosette, Barr, Contract Pharmacal, Cycle Pharms Ltd, Dava Pharms Inc, Elkins Sinn, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, King Pharms, Kv Pharm, Lannett, Lederle, Perrigo, Pharmavite, Purepac Pharm, Sandoz, Scherer Labs, Sun Pharm Industries, Superpharm, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage Pharms, Warner Chilcott, Watson Labs, Whiteworth Town Plsn, Key Pharms, and Schering, and is included in forty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for quinidine sulfate. One supplier is listed for this compound.

Drug Prices for quinidine sulfate

See drug prices for quinidine sulfate

Recent Clinical Trials for quinidine sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of FloridaPhase 1/Phase 2
ALS AssociationPhase 1/Phase 2
Holy Cross Hospital, FloridaPhase 1/Phase 2

See all quinidine sulfate clinical trials

Pharmacology for quinidine sulfate

US Patents and Regulatory Information for quinidine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay CIN-QUIN quinidine sulfate CAPSULE;ORAL 085297-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Scherer Labs QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 085068-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 089839-001 Sep 29, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Schering QUINORA quinidine sulfate TABLET;ORAL 085222-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Cycle Pharms Ltd QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 083640-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 083347-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
McKinsey
Baxter
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.